Description

Dexedrine 5mg tablets

Dexedrine 5mg is the entry-level strength of this central nervous system (CNS) stimulant, formulated to deliver exactly 5 milligrams of active dextroamphetamine sulfate. It is primarily prescribed as a highly targeted option for initiating ADHD or narcolepsy therapy, allowing for precise, gradual dose adjustments.

The drug profile differs structurally and visually depending on whether it is prescribed as a fast-acting tablet or an all-day sustained-release capsule:

Feature	Dexedrine 5mg Immediate-Release (IR) Tablet	Dexedrine Spansule 5mg Sustained-Release (SR) Capsule
Physical Appearance	Orange, multi-sided (triangular or round-cornered), scored for splitting, and debossed with manufacturer identifiers (e.g., SKF/E19).	Hard gelatin capsule featuring a distinctive solid brown cap and a natural or clear body filled with time-release pellets.
Release Mechanism	Dissolves immediately upon ingestion, rapidly introducing the full 5mg dose into the bloodstream.	Releases an initial therapeutic amount promptly, while the remaining medication slowly disperses over 10 to 12 hours.
Dosing Frequency	Typically taken 1 to 3 times daily, spaced 4 to 6 hours apart.	Usually taken just once a day in the morning to prevent evening insomnia.
Key Inactive Ingredients	Calcium sulfate, lactose, gelatin, starch, stearic acid, sucrose, talc, and coloring agents like FD&C Yellow No. 5 & 6.	Cetyl alcohol, ethylcellulose, gelatin, sugar spheres, dibutyl sebacate, and multi-colored dyes.

Core Indications: Indicated for pediatric patients (ages 6 and up) and adults diagnosing with Attention-Deficit Hyperactivity Disorder (ADHD) or Narcolepsy.

How It Functions: Dextroamphetamine targets the synapse regions of brain cells, blocking the reuptake of dopamine and norepinephrine. This maximizes their availability to improve focus, decrease restlessness, and govern behavioral impulse control.

Safety Class: Due to a high vulnerability to misuse, chemical dependency, and diversion, Dexedrine 5mg is rigidly regulated as a Schedule II (CII) controlled substance.